Jennifer Fox's Insider Trades & SAST Disclosures
Jennifer Fox's most recent trade in Myriad Genetics, Inc. was a trade of 63,145 Common Stock done . Disclosure was reported to the exchange on March 13, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Jennifer Fox.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Myriad Genetics, Inc. | Jennifer Fox | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2025 | 63,145 | 124,916 (0%) | 0% | 0 | Common Stock | |
| ProKidney Corp - Ordinary ... | Jennifer A. Fox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Sep 2024 | 9,535 | 9,535 | - | - | Director stock option (right to buy) | |
| Emergent Biosolutions Inc | Jennifer Fox | EVP, Ext Aff, GC, Corp Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2024 | 15,000 | 186,382 (0%) | 0% | 0 | Common Stock | |
| Emergent Biosolutions Inc | Jennifer Fox | EVP, Ext Aff, GC, Corp Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.19 per share. | 08 Jun 2024 | 2,376 | 171,382 (0%) | 0% | 6.2 | 14,707 | Common Stock |
| Apogee Therapeutics Inc. | Jennifer A. Fox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 10,370 | 10,370 | - | - | Stock Option (Right to Buy) | |
| ProKidney Corp - Ordinary ... | Jennifer A. Fox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 62,558 | 62,558 | - | - | Director stock option (right to buy) | |
| Emergent Biosolutions Inc | Jennifer Fox | EVP, Ext Aff, GC, Corp Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2024 | 125,000 | 223,169 | - | - | Employee Stock Options (Right to Buy) | |
| Emergent Biosolutions Inc | Jennifer Fox | EVP, Ext Aff, GC, Corp Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.23 per share. | 29 Feb 2024 | 4,103 | 174,461 (0%) | 0% | 3.2 | 13,253 | Common Stock |
| Emergent Biosolutions Inc | Jennifer Fox | EVP, Ext Aff, GC, Corp Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.39 per share. | 29 Feb 2024 | 703 | 173,758 (0%) | 0% | 3.4 | 2,383 | Common Stock |
| Emergent Biosolutions Inc | Fox Jennifer | EVP, Ext Aff, GC, Corp Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.74 per share. | 23 Feb 2024 | 229 | 178,564 (0%) | 0% | 2.7 | 627 | Common Stock |
| Emergent Biosolutions Inc | Jennifer Fox | EVP, Ext Aff, GC, Corp Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.00 per share. | 11 Nov 2023 | 413 | 178,793 (0%) | 0% | 2 | 826 | Common Stock |
| ProKidney Corp - Ordinary ... | Jennifer A. Fox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jul 2023 | 46,632 | 46,632 | - | - | Director stock option (right to buy) | |
| ProKidney Corp - Ordinary ... | Jennifer A. Fox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jul 2023 | 42,515 | 42,515 | - | - | Director stock option (right to buy) | |
| Emergent Biosolutions Inc | Jennifer Fox | EVP, Ext Aff, GC, Corp Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2023 | 49,231 | 98,169 | - | - | Employee Stock Option (Right to buy) | |
| Emergent Biosolutions Inc | Jennifer Fox | EVP, Ext Aff, GC, Corp Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2023 | 49,231 | 179,206 (0%) | 0% | 0 | Common Stock | |
| Emergent Biosolutions Inc | Jennifer Fox | EVP, Ext Aff, GC, Corp Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2023 | 24,616 | 129,975 (0%) | 0% | 0 | Common Stock | |
| Emergent Biosolutions Inc | Jennifer Fox | EVP, Ext Aff, GC, Corp Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2023 | 12,308 | 105,359 (0%) | 0% | 0 | Common Stock | |
| Emergent Biosolutions Inc | Jennifer Fox | EVP, Ext Aff, GC, Corp Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2023 | 12,308 | 48,938 | - | - | Employee Stock Options (Right to Buy) | |
| Emergent Biosolutions Inc | Jennifer Fox | EVP, Ext Aff, GC, Corp Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2023 | 6,154 | 93,051 (0%) | 0% | 0 | Common Stock | |
| Nuvation Bio Inc - Ordinar... | Jennifer A. Fox | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 600,000 | 600,000 | - | - | Stock Option (Right to Buy) | |
| Emergent Biosolutions Inc | Jennifer Fox | EVP, Ext Aff, GC, Corp Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.38 per share. | 28 Feb 2023 | 1,005 | 86,897 (0%) | 0% | 12.4 | 12,442 | Common Stock |
| Emergent Biosolutions Inc | Jennifer Fox | EVP, Ext Aff, GC, Corp Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.71 per share. | 23 Feb 2023 | 258 | 87,902 (0%) | 0% | 13.7 | 3,537 | Common Stock |
| Emergent Biosolutions Inc | Jennifer Fox | EVP, Ext Aff, GC, Corp Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.30 per share. | 23 Feb 2023 | 231 | 88,160 (0%) | 0% | 14.3 | 3,303 | Common Stock |
| Emergent Biosolutions Inc | Jennifer Fox | EVP, Ext Aff, GC, Corp Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2022 | 42,135 | 88,391 (0%) | 0% | 0 | Common Stock | |
| Emergent Biosolutions Inc | Jennifer Fox | EVP, Ext Aff, GC, Corp Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2022 | 14,045 | 46,256 (0%) | 0% | 0 | Common Stock | |
| Emergent Biosolutions Inc | Jennifer Fox | EVP, Ext Aff, GC, Corp Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.00 per share. | 11 Nov 2022 | 416 | 32,211 (0%) | 0% | 15 | 6,240 | Common Stock |
| ProKidney Corp - Ordinary ... | Jennifer A. Fox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Sep 2022 | 129,370 | 129,370 | - | - | Stock option (right to buy) | |
| Nuvation Bio Inc - Ordinar... | Jennifer A. Fox | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Aug 2022 | 480,000 | 480,000 | - | - | Stock Option (Right to Buy) | |
| Emergent Biosolutions Inc | Jennifer Fox | EVP, Ext Aff, GC, Corp Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 26,584 | 26,584 | - | - | Employee Stock Options (Right to Buy) | |
| Emergent Biosolutions Inc | Jennifer Fox | EVP, Ext Aff, GC, Corp Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 17,794 | 32,627 (0%) | 0% | 0 | Common Stock | |
| Emergent Biosolutions Inc | Jennifer Fox | EVP, Ext Aff, GC, Corp Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 7,583 | 14,833 (0%) | 0% | 0 | Common Stock | |
| Nuvation Bio Inc - Ordinar... | Jennifer A. Fox | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 600,000 | 600,000 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges